4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-032073
EVP & Chief R & QA Officer sold 25,860 shares at $50.03 ($1,293,776)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clark Mitchall G. EVP & Chief R & QA Officer | 2018-05-18 | Sale | −25,860 | $50.03 | $1,293,776 | 107,972 | D |
| Open-market sales · 25,860 sh · avg $50.03 · $1,293,776 | |||||||
Loading xslF345X03/doc4.xml…